NCT02916238View on ClinicalTrials.gov

Measurement-based Care for Depression in Resource-Poor Settings

PHASE4CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Major Depression

Interventions

DRUG

Fluoxetine

Fluoxetine prescribed and dispensed beginning at 10 mg daily; side effects and symptoms monitored biweekly; dosage increased to 20 mg., then by 20 mg. increments according to protocol algorithm based on PHQ-9 score to a maximum dose of 60 mg.

BEHAVIORAL

Enhanced Usual Care

Depression symptoms monitored at 3 month intervals; results from PHQ-9 available to ART clinic physicians.

Trial Locations (1)

Unknown

GHESKIO Centers, Port-au-Prince

All Listed Sponsors

lead

Florida International University

OTHER

NCT02916238 - Measurement-based Care for Depression in Resource-Poor Settings | Biotech Hunter | Biotech Hunter